Hoerter Steven L.

Director at C4 Therapeutics, Inc. · on record since Nov 21, 2024
Director at MBX Biosciences, Inc. · on record since Apr 22, 2026
See Remarks at Clovis Oncology, Inc. · on record since Jun 6, 2013
Director at Ignyta, Inc. · on record since Dec 9, 2016
Director at VYNE Therapeutics Inc. · on record since Jul 29, 2026
Chief Commercial Officer at AGIOS PHARMACEUTICALS, INC. · on record since Feb 18, 2016
Director at Deciphera Pharmaceuticals, Inc. · on record since May 21, 2018
Director at CONSTELLATION PHARMACEUTICALS INC · on record since Sep 5, 2018
President and CEO at Deciphera Pharmaceuticals, Inc. · on record since Mar 20, 2019
Director at Oric Pharmaceuticals, Inc. · on record since Aug 16, 2021
President and CEO at MBX Biosciences, Inc. · on record since Aug 4, 2026

Insider trading activity of Hoerter Steven L.

Transactions on record: 141; since Mar 5, 2012

Open-market buys: 1; $265K

Open-market sells: 19; $9.4M

Companies traded: 8; last filing Aug 4, 2026

Figures computed from official regulatory filings — .

Companies where Hoerter Steven L. has traded

MBX Biosciences, Inc.12 tx · $265K · Aug 4, 2026
C4 Therapeutics, Inc.3 tx · Jun 26, 2026
Oric Pharmaceuticals, Inc.6 tx · Jan 6, 2026
Deciphera Pharmaceuticals, Inc.46 tx · $2.1M · Jun 11, 2024
CONSTELLATION PHARMACEUTICALS INC9 tx · Jul 23, 2021
42 tx · $6.1M · Mar 5, 2019
4 tx · Feb 12, 2018
19 tx · $5M · Mar 9, 2015

Track record of Hoerter Steven L.

Insufficient history for a statistical track record (fewer than 5 open-market buys).

Transaction history of Hoerter Steven L.

Co-insiders of Hoerter Steven L.

This page republishes public regulatory disclosures.

Company	Filed	Type	Qty	Price	Value · USD	Src
MBX Biosciences, Inc.	Aug 4, 2026	Award	71,000	0.00 USD	—	SEC
MBX Biosciences, Inc.	Aug 4, 2026	AwardD (derivative)	331,000	0.00 USD	—	SEC
C4 Therapeutics, Inc.	Jun 26, 2026	AwardD (derivative)	62,000	0.00 USD	—	SEC
MBX Biosciences, Inc.	Jun 5, 2026	AwardD (derivative)	12,500	0.00 USD	—	SEC
MBX Biosciences, Inc.	May 4, 2026	Award	11,938	0.00 USD	—	SEC
MBX Biosciences, Inc.	May 4, 2026	AwardD (derivative)	74,249	0.00 USD	—	SEC
MBX Biosciences, Inc.	Apr 22, 2026	AwardD (derivative)	33,751	0.00 USD	—	SEC
MBX Biosciences, Inc.	Apr 22, 2026	AwardD (derivative)	0	0.00 USD	—	SEC
Oric Pharmaceuticals, Inc.	Jan 6, 2026	AwardD (derivative)	40,000	0.00 USD	—	SEC
MBX Biosciences, Inc.	Nov 25, 2025	AwardD (derivative)	8,000	0.00 USD	—	SEC
MBX Biosciences, Inc.	Nov 7, 2025	AwardD (derivative)	100,000	0.00 USD	—	SEC
MBX Biosciences, Inc.	Oct 20, 2025	Buy	20,000	13.25 USD	$265K	SEC
C4 Therapeutics, Inc.	Jun 20, 2025	AwardD (derivative)	35,500	0.00 USD	—	SEC
MBX Biosciences, Inc.	Jun 6, 2025	AwardD (derivative)	16,000	0.00 USD	—	SEC
MBX Biosciences, Inc.	Apr 9, 2025	AwardD (derivative)	32,000	0.00 USD	—	SEC
Oric Pharmaceuticals, Inc.	Jan 6, 2025	AwardD (derivative)	35,000	0.00 USD	—	SEC
C4 Therapeutics, Inc.	Nov 21, 2024	AwardD (derivative)	65,000	0.00 USD	—	SEC
Oric Pharmaceuticals, Inc.	Jun 14, 2024	AwardD (derivative)	25,600	0.00 USD	—	SEC
Deciphera Pharmaceuticals, Inc.	Jun 11, 2024	OtherD (derivative)	-270,357	—	—	SEC
Deciphera Pharmaceuticals, Inc.	Jun 11, 2024	Award	286,075	—	—	SEC
Deciphera Pharmaceuticals, Inc.	Jun 11, 2024	OtherD (derivative)	-415,000	—	—	SEC
Deciphera Pharmaceuticals, Inc.	Jun 11, 2024	OtherD (derivative)	-298,100	—	—	SEC
Deciphera Pharmaceuticals, Inc.	Jun 11, 2024	OtherD (derivative)	-250,000	—	—	SEC
Deciphera Pharmaceuticals, Inc.	Jun 11, 2024	OtherD (derivative)	-395,735	—	—	SEC
Deciphera Pharmaceuticals, Inc.	Jun 11, 2024	Other	-286,075	—	—	SEC

Company	Filed	Type	Qty	Price	Value · USD	Src
MBX Biosciences, Inc.	Aug 4, 2026	Award	71,000	0.00 USD	—	SEC
MBX Biosciences, Inc.	Aug 4, 2026	AwardD (derivative)	331,000	0.00 USD	—	SEC
C4 Therapeutics, Inc.	Jun 26, 2026	AwardD (derivative)	62,000	0.00 USD	—	SEC
MBX Biosciences, Inc.	Jun 5, 2026	AwardD (derivative)	12,500	0.00 USD	—	SEC
MBX Biosciences, Inc.	May 4, 2026	Award	11,938	0.00 USD	—	SEC
MBX Biosciences, Inc.	May 4, 2026	AwardD (derivative)	74,249	0.00 USD	—	SEC
MBX Biosciences, Inc.	Apr 22, 2026	AwardD (derivative)	33,751	0.00 USD	—	SEC
MBX Biosciences, Inc.	Apr 22, 2026	AwardD (derivative)	0	0.00 USD	—	SEC
Oric Pharmaceuticals, Inc.	Jan 6, 2026	AwardD (derivative)	40,000	0.00 USD	—	SEC
MBX Biosciences, Inc.	Nov 25, 2025	AwardD (derivative)	8,000	0.00 USD	—	SEC
MBX Biosciences, Inc.	Nov 7, 2025	AwardD (derivative)	100,000	0.00 USD	—	SEC
MBX Biosciences, Inc.	Oct 20, 2025	Buy	20,000	13.25 USD	$265K	SEC
C4 Therapeutics, Inc.	Jun 20, 2025	AwardD (derivative)	35,500	0.00 USD	—	SEC
MBX Biosciences, Inc.	Jun 6, 2025	AwardD (derivative)	16,000	0.00 USD	—	SEC
MBX Biosciences, Inc.	Apr 9, 2025	AwardD (derivative)	32,000	0.00 USD	—	SEC
Oric Pharmaceuticals, Inc.	Jan 6, 2025	AwardD (derivative)	35,000	0.00 USD	—	SEC
C4 Therapeutics, Inc.	Nov 21, 2024	AwardD (derivative)	65,000	0.00 USD	—	SEC
Oric Pharmaceuticals, Inc.	Jun 14, 2024	AwardD (derivative)	25,600	0.00 USD	—	SEC
Deciphera Pharmaceuticals, Inc.	Jun 11, 2024	OtherD (derivative)	-270,357	—	—	SEC
Deciphera Pharmaceuticals, Inc.	Jun 11, 2024	Award	286,075	—	—	SEC
Deciphera Pharmaceuticals, Inc.	Jun 11, 2024	OtherD (derivative)	-415,000	—	—	SEC
Deciphera Pharmaceuticals, Inc.	Jun 11, 2024	OtherD (derivative)	-298,100	—	—	SEC
Deciphera Pharmaceuticals, Inc.	Jun 11, 2024	OtherD (derivative)	-250,000	—	—	SEC
Deciphera Pharmaceuticals, Inc.	Jun 11, 2024	OtherD (derivative)	-395,735	—	—	SEC
Deciphera Pharmaceuticals, Inc.	Jun 11, 2024	Other	-286,075	—	—	SEC